PPJ Healthcare Enterprises Inc (PPJE)

[Arthur]

PPJE Disclosure Statement doesn't square with their financials:

PERIOD ENDING MARCH 31, 2017
Common Stock
$0.00001 Par Value per Share
10,000,000,000 Authorized
3,802,203,338 Issued and Outstanding

OTC Markets Symbol: PPJE CUSIP No. 35369D407

Non-Dilutive Common Stock
$0.0001 Par Value per Share 20,000,000,000 Authorized
None Issued
(This Class of shares authorized to cover shareholders’ loss)

So PPJE has either 7 billion shares outstanding, or 3.8 billion.

With an extra 20 billion shares that are absolutely non-dilutive, and that do not cost anything to anyone.

Common Stock
$0.0001 Par Value per Share
Twenty Billion (20,000,000,000) Authorized
7,010,836,058 Shares Issued and Outstanding as of March 31, 2017
Restricted shares 3,737,177,267
Public Float 3,285,781,791
OTC Markets Symbol: PPJE
CUSIP No. 35369D505.

Ah, 7 billion O/S, but the float is "only" 3.2 billon shares, that's more like it.

8. The number of total employees and number of full-time employees.
The number of total employees and number of full-time employees usually varies from 8 to 22, increased or reduced as per need for the time. But currently we have 76 employees through partner in medical bill processing, appeal and collection.

Today, the unique process of the Automated Biller is still one of its kind. Through research and development, the product is scheduled to be enhanced by allowing physicians to complete all their medical billing through a hand-held device such as a PDA or today’s Ipad. The revenue potential of the Automated Biller is extreme; But the product needs upgrade then it only has to get to the market to almost sell itself.

The Issuer estimates that it has spent the following amounts on research and development:
a. 2010 - $24,000 b. 2011 - $10,300 c. 2012 - $18,000 c. 2013 - $6,500 d. 2014 - $6,500
e. 2015 – $6,102
f. 2016--$0.00[/quote]

Litigation
The Company filed lawsuit against its former Lawyer Michael J. Hemming for negligence in representation in trial against Narinder Singh Grewal, MD during 2009 to 2014.
The Company has no other current, pending or threatened legal proceedings or administrative actions either by or against the Company issuer that could have a material effect on the issuer's business, financial condition, or operations and any current, past or pending trading suspensions

Employees
As of March 31, 2017, we had eight employees, including officers and directors. We believe that we have been successful in attracting experienced and capable personnel. All our employees have entered agreements with us requiring them not to compete or disclose our proprietary information. Our employees are not represented by any labor union. We believe that relations with our employees are excellent. Usually the number of total employees and number of full-time employees varies between 10 – 22, increased or reduced as per need for the time.

During 2016, pre reverse split Ms. Basu accepted 2,100,000,000 shares of Common Stock for compensation and Dajit Kaur accepted 100,000 shares of Common Stock as compensation.
Post reverse split Ms. Basu received 300,000,000 common stock for management of all lawsuits.